One would think that at least one of the six board members would have a dose of common sense, and might raise his or her hand after going back and listening to their own shareholder meeting to signal that ‘gee, guys, maybe we didn’t do a good job of instilling confidence with our shareholders.’ That would be too much to expect.
Since all common sense is completely gone, as noted by the fact that the CEO signaled that the company has nothing in the pipeline and nothing lined up in the way of financing to support litigation to protect the company’s IP, what could possibly be going through their minds? Doesn’t it stand to reason that they should simply start taking action? Perhaps at least trying different things? What about something like this:
1. Let’s start working with a sense of urgency, instead of revealing that you are only capable of accomplishing one thing at a time;
2. Inform shareholders that you will now make a concerted effort to be more communicative. We realize you can’t divulge proprietary info, but that doesn’t mean you can’t post a monthly paragraph on your own website to let shareholders know you are at least trying. You’ve lost everyone’s respect and confidence, so do something to restore it;
3. Since the delay in issuing the 10-Q was embarrassing and laughable, why don’t you just hire a couple of interns that can help pull information together, with little to no cost. Get it done and stop the nonsense;
4. On your own website, you reference the myriad of applications for SVM-RFE, yet it is clear you aren’t doing anything to take advantage of them. How about sizing each opportunity up, and developing a potential plan of action for each;
5. Spend $300 to create an LLC that can operate as a wholly-owned subsidiary of HDC, but with a focus on a sector or two outside of biomarker discovery;
6. Spend another $300 on a separate LLC through which HDC creates an advisory service, with SVM-RFE the ‘differentiator’ for things like predictive modeling, population health strategies, etc.;
7. After you set these up, announce it to shareholders via the website to generate some enthusiasm;
8. Since we have limited capital, why don’t you get creative and post a position or two aimed at trying to attract individuals with tremendous technical and/or sales skills who might desire to take a gamble on an opportunity to truly develop a business segment. No salary now. Compensation based solely on success, with the opportunity to run those businesses as they develop. What’s the harm? A few dollars to post a job or two?
9. If you can’t fight Intel, at least try to take the SVM-RFE to Nvidia, Google, IBM, AMD, or others to strike a licensing agreement. If we are letting the IP go to waste, at least take advantage of a co-licensing arrangement for our IP.
10. Reach out to Albitar and see if he wants to run with the prostate liquid biopsy test via his CA lab; for that matter, ask him if Neo developed tests using SVM-RFE (and why haven’t we pursued the infringement further with them with the SEC, once the arbitration was settled?);
Perhaps I’m making too much sense. That said, I think I accomplished more in the last 10 minutes than the HDC team has in the last 5 months.
